Dynamic Advisor Solutions LLC Abb Vie Inc. Transaction History

Dynamic Advisor Solutions LLC

$3.28 Billion
Q3 2024

A detailed history of Dynamic Advisor Solutions LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dynamic Advisor Solutions LLC holds 63,292 shares of ABBV stock, worth $11 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

63,292

Previous 64,649 2.1%

Holding current value

$11 Million

Previous $11.1 Million 12.72%

% of portfolio

0.38%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$163.84 - $199.33 $222,330 - $270,490	-1,357 Reduced 2.1%	63,292 $12.5 Million
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $20,896 - $24,402	-135 Reduced 0.21%	64,649 $11.1 Million
Q1 2024 Apr 12, 2024	SELL	$159.82 - $182.1 $366,946 - $418,101	-2,296 Reduced 3.42%	64,784 $11.8 Million
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $4.58 Million - $5.16 Million	33,269 Added 98.4%	67,080 $10.4 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $704,687 - $815,778	5,275 Added 18.49%	33,811 $5.04 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $249,913 - $311,001	-1,886 Reduced 6.2%	28,536 $3.84 Million
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $574,246 - $661,330	3,971 Added 15.01%	30,422 $4.85 Million
Q4 2022 Jan 12, 2023	BUY	$138.31 - $165.87 $127,383 - $152,766	921 Added 3.61%	26,451 $0
Q3 2022 Oct 20, 2022	BUY	$134.21 - $153.93 $288,551 - $330,949	2,150 Added 9.2%	25,530 $3.43 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $147,391 - $187,382	-1,071 Reduced 4.38%	23,380 $3.58 Million
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $41,705 - $51,745	-316 Reduced 1.28%	24,451 $3.96 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $202,290 - $255,956	-1,883 Reduced 7.07%	24,767 $3.35 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $47,773 - $54,230	449 Added 1.71%	26,650 $2.88 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $607,272 - $676,536	5,772 Added 28.25%	26,201 $2.95 Million
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $620,961 - $683,603	-6,070 Reduced 22.91%	20,429 $2.21 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $264,409 - $356,980	-3,285 Reduced 11.03%	26,499 $2.84 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $24,054 - $28,232	-280 Reduced 0.93%	29,784 $2.61 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $148,500 - $198,716	2,024 Added 7.22%	30,064 $2.95 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $32,443 - $49,188	503 Added 1.83%	28,040 $2.14 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $49,336 - $61,731	684 Added 2.55%	27,537 $2.44 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $11,462 - $13,781	-182 Reduced 0.67%	26,853 $2.03 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $240,330 - $307,198	3,658 Added 15.65%	27,035 $1.97 Million
Q1 2019 Apr 10, 2019	SELL	$77.14 - $90.79 $930,539 - $1.1 Million	-12,063 Reduced 34.04%	23,377 $1.88 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $135,147 - $166,673	-1,736 Reduced 4.67%	35,440 $2.85 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $27,473 - $30,541	309 Added 0.84%	37,176 $3.52 Million
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $515,965 - $610,503	5,747 Added 18.47%	36,867 $3.42 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $1.71 Million - $2.29 Million	-18,556 Reduced 37.35%	31,120 $2.95 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $885,031 - $970,511	-9,882 Reduced 16.59%	49,676 $4.8 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $4.16 Million - $5.31 Million	59,558	59,558 $5.29 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.

Account

Dynamic Advisor Solutions LLC Abb Vie Inc. Transaction History